NASDAQ
NASDAQ US (NASDAQ) Stocks
Showing 1701–1750 of 3348
| Symbol | Name | Sector | Verdict | Confidence | Archetype | Lenses in buy | Buy zone |
|---|---|---|---|---|---|---|---|
| MZTI | MARZETTI CO | Consumer Defensive | Avoid | ●○○ Low | Franchise | 0/4 | Overvalued |
| NAGE | Niagen Bioscience, Inc. | Healthcare | Avoid | ●○○ Low | Earnings Suspect | 0/4 | Overvalued |
| NAMI | Jinxin Technology Holding Co | Communication Services | Avoid | ●●○ Medium | Distressed/Deficit | 0/4 | Overvalued |
| NAMS | NewAmsterdam Pharma Co N.V. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NAMSW | NewAmsterdam Pharma Co N.V. | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued | |
| NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | Avoid | ●●○ Medium | Franchise | 0/4 | Overvalued |
| NAVN | Navan, Inc. | Technology | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NB | NIOCORP DEVELOPMENTS LTD | Basic Materials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NBIS | Nebius Group N.V. | Communication Services | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued |
| NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | Avoid | ●●● High | Franchise | 0/4 | Overvalued |
| NBP | NovaBridge Biosciences | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NCEW | New Century Logistics (BVI) Ltd | Industrials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NCI | Neo-Concept International Group Holdings Ltd | Consumer Cyclical | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued |
| NCMI | National CineMedia, Inc. | Communication Services | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NCNA | NuCana plc | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NDRA | ENDRA Life Sciences Inc. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NDSN | NORDSON CORP | Industrials | Avoid | ●●● High | Asset-Light Compounder | 0/4 | Overvalued |
| NEGG | Newegg Commerce, Inc. | Consumer Cyclical | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NEO | NEOGENOMICS INC | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NEOV | NeoVolta Inc. | Industrials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NEOVW | NeoVolta Inc. | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued | |
| NEPH | NEPHROS INC | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NESR | National Energy Services Reunited Corp. | Energy | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued |
| NEUP | Neuphoria Therapeutics Inc. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NEXM | NexMetals Mining Corp. | Basic Materials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NEXN | Nexxen International Ltd. | Communication Services | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued |
| NFLX | NETFLIX INC | Communication Services | Avoid | ●●○ Medium | Asset-Light Compounder | 0/4 | Overvalued |
| NGEN | NERVGEN PHARMA CORP. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NGNE | Neurogene Inc. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NHIC | NewHold Investment Corp. III | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued | |
| NHICU | NewHold Investment Corp. III | Avoid | ●○○ Low | No-Moat | 0/4 | Overvalued | |
| NHP | National Healthcare Properties, Inc. | Real Estate | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NHPAP | National Healthcare Properties, Inc. | Real Estate | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NHPBP | National Healthcare Properties, Inc. | Real Estate | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NIKI | Niki BioSolutions, Inc. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NIOBW | NIOCORP DEVELOPMENTS LTD | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued | |
| NIU | Niu Technologies | Consumer Cyclical | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NKTR | NEKTAR THERAPEUTICS | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NMAD | NOMAD POWER SOLUTIONS, INC. | Industrials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NMRA | Neumora Therapeutics, Inc. | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NMRK | NEWMARK GROUP, INC. | Real Estate | Avoid | ●●● High | Franchise | 0/4 | Overvalued |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NNBR | NN INC | Industrials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NNE | Nano Nuclear Energy Inc. | Industrials | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NNNN | Anbio Biotechnology | Healthcare | Avoid | ●○○ Low | Earnings Suspect | 0/4 | Overvalued |
| NOMA | Nomadar Corp. | Consumer Cyclical | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NOVT | NOVANTA INC | Technology | Avoid | ●●○ Medium | Franchise | 0/4 | Overvalued |
| NOVTU | NOVANTA INC | Technology | Avoid | ●●● High | Franchise | 0/4 | Overvalued |
| NPCE | NeuroPace Inc | Healthcare | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |
| NPT | Texxon Holding Ltd | Consumer Cyclical | Avoid | ●○○ Low | Distressed/Deficit | 0/4 | Overvalued |